CLIA Kit for Epiregulin (EREG)

EPR; ER; Proepiregulin

  • CLIA Kit for Epiregulin (EREG) Packages (Simulation)
  • CLIA Kit for Epiregulin (EREG) Packages (Simulation)
  • CLIA Kit for Epiregulin (EREG) Results demonstration
  • SCB945Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Epiregulin (EREG)

This assay has high sensitivity and excellent specificity for detection of Epiregulin (EREG).
No significant cross-reactivity or interference between Epiregulin (EREG) and analogues was observed.

Recovery of the CLIA Kit for Epiregulin (EREG)

Matrices listed below were spiked with certain level of recombinant Epiregulin (EREG) and the recovery rates were calculated by comparing the measured value to the expected amount of Epiregulin (EREG) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-96 92
EDTA plasma(n=5) 79-103 87
heparin plasma(n=5) 98-105 101

Precision of the CLIA Kit for Epiregulin (EREG)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Epiregulin (EREG) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Epiregulin (EREG) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Epiregulin (EREG)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Epiregulin (EREG) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-95% 85-104% 87-95% 81-102%
EDTA plasma(n=5) 92-99% 82-98% 94-102% 78-99%
heparin plasma(n=5) 83-95% 87-95% 94-104% 90-98%

Stability of the CLIA Kit for Epiregulin (EREG)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Epiregulin (EREG)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Epiregulin (EREG)

The microplate provided in this kit has been pre-coated with an antibody specific to Epiregulin (EREG). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Epiregulin (EREG). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Epiregulin (EREG) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPB945Hu01 Recombinant Epiregulin (EREG) Positive Control; Immunogen; SDS-PAGE; WB.
PAB945Hu01 Polyclonal Antibody to Epiregulin (EREG) WB; ICC; IHC-P; IHC-F; ELISA.
MAB945Hu22 Monoclonal Antibody to Epiregulin (EREG) WB; IHC; ICC; IP.
SEB945Hu ELISA Kit for Epiregulin (EREG) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB945Hu CLIA Kit for Epiregulin (EREG) Chemiluminescent immunoassay for Antigen Detection.